1. Dysregulation of non-coding RNAs in gastric cancer
    Qing Yang, 2015, World Journal of Gastroenterology CrossRef
  2. MiR-135a-5p modulates biological functions of thyroid carcinoma cells via targeting VCAN 3′-UTR
    Xue Zhao et al, 2017, Cancer Biomarkers CrossRef
  3. MicroRNAs in gastric cancer: Biomarkers and therapeutic targets
    Soudeh Ghafouri-Fard et al, 2020, Gene CrossRef
  4. Physiological and Pathological Functions of Mammalian MicroRNAs
    X. Ma et al, 2018, Comprehensive Toxicology CrossRef
  5. The impact of infertility diagnosis on embryo-endometrial dialogue
    Jason C Parks et al, 2018, Reproduction CrossRef
  6. Noncoding RNAs in gastric cancer: implications for drug resistance
    Ling Wei et al, 2020, Molecular Cancer CrossRef
  7. Hepatitis B core antigen modulates exosomal miR-135a to target vesicle-associated membrane protein 2 promoting chemoresistance in hepatocellular carcinoma
    Xiao-Cui Wei et al, 2021, World Journal of Gastroenterology CrossRef
  8. An emphasis on the interaction of signaling pathways highlights the role of miRNAs in the etiology and treatment resistance of gastric cancer
    Doaa Fathi et al, 2023, Life Sciences CrossRef
  9. Mechanisms of Action And Clinical Implications of MicroRNAs in the Drug Resistance of Gastric Cancer
    Ying Liu et al, 2021, Frontiers in Oncology CrossRef
  10. Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
    Roberto Mattioli et al, 2023, Molecular Aspects of Medicine CrossRef
  11. Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review)
    Chao Chen et al, 2019, International Journal of Oncology CrossRef
  12. The related miRNAs involved in doxorubicin resistance or sensitivity of various cancers: an update
    Zahra Torki et al, 2021, Cancer Chemotherapy and Pharmacology CrossRef
  13. Non-coding RNAs underlying chemoresistance in gastric cancer
    Arash Poursheikhani et al, 2020, Cellular Oncology CrossRef
  14. IncRNA AC004943.2 regulates miR‐135a‐5p and PTK2/P13K axis to promote laryngeal squamous cell carcinoma progression
    Xiaowen Zhu et al, 2024, Journal of Cell Communication and Signaling CrossRef
  15. Can the chemotherapeutic agents perform anticancer activity though miRNA expression regulation? Proposing a new hypothesis
    Chiranjib Chakraborty et al, 2015, Protoplasma CrossRef
  16. Non-coding RNA in drug resistance of gastric cancer
    Ya-Jun Luo et al, 2019, World Journal of Gastrointestinal Oncology CrossRef
  17. Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer
    Wanli Yang et al, 2017, Expert Opinion on Therapeutic Targets CrossRef